Literature DB >> 6310356

Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A.

M von Knebel Doeberitz, G W Bornkamm, H zur Hausen.   

Abstract

To establish spontaneously outgrowing EBV (Epstein-Barr virus) transformed lymphoid cell lines from healthy EBV-seropositive adults different culture conditions were investigated. The effect of T-cell depletion was compared with that of adding Cyclosporin A (CSA) to unseparated mononuclear blood cells, either at the onset of cultivation or after 3 weeks. The highest frequency of spontaneous outgrowth of EBV-transformed cells was obtained in unseparated cultures when the addition of CSA was delayed. The presence of unimpaired T cells at the onset of the culture period appeared to have a favourable effect on the spontaneous outgrowth of EBV-carrying lymphoblastoid cell lines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310356     DOI: 10.1007/bf02124509

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  39 in total

1.  Absence of infectious Epstein-Barr virus in blood in acute infectious mononucleosis.

Authors:  A B Rickinson; M A Epstein; D H Crawford
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

3.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

4.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

5.  T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.

Authors:  G Tosato; I T Magrath; R M Blaese
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

6.  Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation.

Authors:  D J Moss; A B Rickinson; L E Wallace; M A Epstein
Journal:  Nature       Date:  1981-06-25       Impact factor: 49.962

7.  Long-term culture of normal mouse B lymphocytes.

Authors:  M Howard; S Kessler; T Chused; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

9.  Identification of a human T lymphocyte surface protein associated with the E-rosette receptor.

Authors:  M Kamoun; P J Martin; J A Hansen; M A Brown; A W Siadak; R C Nowinski
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  7 in total

1.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 2.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

Review 3.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

4.  Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus.

Authors:  P K Kataaha; C A Facer; E J Holborow
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

5.  Glycosylphosphatidylinositol (GPI)-anchored surface antigens in the allogeneic activation of T cells.

Authors:  J Schubert; A Stroehmann; C Scholz; R E Schmidt
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.

Authors:  H J Delecluse; E Kremmer; J P Rouault; C Cour; G Bornkamm; F Berger
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

7.  An Epstein-Barr virus-associated superantigen.

Authors:  N Sutkowski; T Palkama; C Ciurli; R P Sekaly; D A Thorley-Lawson; B T Huber
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.